Home / Taiwan Excellence Award / Award Winning Products / Product Details

Integrated Genetic Analyzer
Industry type:Health and precision instrument
Product model number:QsepUltra
BIOPTIC INC.
award 3

The information related to this product could not be shown due to medical law, please contact the company directly for more information.

https://www.bioptic.com.tw/

Contact online

About BIOPTIC INC.

BiOptic Inc. is the only manufacturer of capillary electrophoresis instruments in Asia. We provide an open platform for three main fields, including biotechnology research, genetic testing and clinical diagnosis, to facilitate the related product development, and also, to bring improvement to biotech industries. Our team has more than 40 years of experience in the CE industry. By providing a good quality of products, professional technical support and excellent customer services, BiOptic earned a reputation by word-of-mouth through our customers worldwide. BiOptic currently has more than 40 distributors and provides products and services to customers in more than 50 countries around the world. We gather talents in each field to continue the innovative R&D, and to show the abilities of Taiwan's biotechnology industry to the world.

https://www.bioptic.com.tw/

BiOptic was established in 2004. In the beginning, we started our OEM business with the company eGene. Until 2007, eGene was acquired by the German biotech company QIAGEN, and we started the OEM for QIAGEN. Since then, we have realized that OEM will no longer be the solution for the company's future. We then started to develop our own brand and products in the same year, and this is where BiOptic came from. Finally, after five years of research and development, in 2012, the first capillary electrophoresis instrument made in Taiwan was commercialized. With the continuous participation in international exhibitions, BiOptic has expanded our business to the globe year by year. BiOptic strives to provide innovative solutions for global users in the fields of biotechnology research, genetic testing, clinical diagnosis, etc. while taking into fully automation, high performance, and cost-effectiveness, opening a new chapter in global biotechnology industries.

Contact info